Acute Myelogenous Leukemia (AML) has a 5 year survival rate of approximately 20% and kills about 8,000 people/year in the U.S. Until recently, only two mutations had been identified as contributing factors, but researchers at the Washington University School of Medicine in St. Louis hav...
The use of brain scans to detect Alzheimer's disease was the topic of a lecture by Dr. John Csernansky, director of the Silvio O. Conte Center for Neuroscience Research at Washington University, St. Louis, at Vanderbilt University March 9. The lecture was part of the Brainstorm 2006 lecture...
Thu, Mar 16 | from Vanderbilt University News